Listing 1 - 9 of 9 |
Sort by
|
Choose an application
Choose an application
Gene expression regulation --- Genes, tumor suppressor --- Genes --- Transcription factors --- Cell cycle proteins --- biosynthesis
Choose an application
Cancer --- Oncogenes --- Transcription factors --- Tumor proteins --- Drug Design --- Genes, Tumor Suppressor --- Neoplasms --- Oncogene Proteins --- Receptors, Cytoplasmic and Nuclear --- Transcription Factors --- Chemotherapy --- physiology --- drug therapy
Choose an application
Pathological biochemistry --- Human medicine --- medische biochemie --- biomedische wetenschappen --- geneeskunde --- Tumor suppressor proteins. --- Tumor Suppressor Proteins. --- Antioncoproteins --- Growth suppressor proteins --- Metastasis suppressor proteins --- Proteins --- Antioncogenes --- Growth Suppressor Proteins --- Metastasis Suppressor Proteins --- Proteins, Growth Suppressor --- Proteins, Metastasis Suppressor --- Proteins, Tumor Suppressor --- Genes, Tumor Suppressor --- Tumors --- Carcinomes --- Malalties neoplàstiques --- Neoplàsies --- Neoplasmes --- Patologia --- Càncer --- Feocromocitoma --- Fibromes --- Marcadors tumorals --- Mesotelioma --- Miomes --- Pòlips (Patologia) --- Sarcoïdosi --- Teratoma --- Tumors de parts toves --- Tumors en els animals --- Classificació de tumors --- Oncologia --- Quistos
Choose an application
Our understanding of human cancer in the past 40 years has been driven by linking innovative concepts and cutting edge technologies to key problems identified by clinical research. Some of the successes in cancer genetics identified from clinical work have been the identification of specific gene deletions in human chromosomes, the use of PCR-based cloning methodologies to identify and clone human cancer genes, the validation of the human cancer genes using transgenetic technologies in the mouse, and the ability to sequence whole genomes that has recently allowed a collation of all somatic and germline mutations in a human genome. In the same generation, entirely different disciplines involved in basic life science research have used model organisms like yeast, flies, worms, and cancer causing animal viruses as tools to develop windows to see into the machinery of the cell life cycle. The discoveries of pro-apoptotic genes, oncogenes, and covalent control mechanisms like phosphorylation and ubiquitination using the tools of science and technology have all been awarded Nobel prizes for their contribution to our understanding of how cells work. The discovery of p53 using the tumor causing animal virus SV40 falls into this pioneering period of biological and medical research.
Cell Transformation, Neoplastic -- genetics. --- Genes, p53. --- p53 antioncogene. --- p53 protein. --- p53 antioncogene --- p53 protein --- Neoplastic Processes --- Biology --- Genes, Tumor Suppressor --- Biological Science Disciplines --- Genes, Neoplasm --- Pathologic Processes --- Genes, Recessive --- Neoplasms --- Natural Science Disciplines --- Pathological Conditions, Signs and Symptoms --- Genes --- Diseases --- Genome Components --- Disciplines and Occupations --- Genome --- Genetic Structures --- Genetic Phenomena --- Phenomena and Processes --- Genetics --- Genes, p53 --- Cell Transformation, Neoplastic --- Medicine --- Health & Biological Sciences --- Oncology --- Protein p53 --- Protein TP53 --- TP53 protein --- p53 gene --- p53 suppressor gene --- Medicine. --- Cancer research. --- Biomedicine. --- Cancer Research. --- Cancer research --- Clinical sciences --- Medical profession --- Human biology --- Life sciences --- Medical sciences --- Pathology --- Physicians --- DNA-binding proteins --- Phosphoproteins --- Tumor suppressor proteins --- Antioncogenes --- Oncology. --- Tumors
Choose an application
The primary cause of death related to cancers can be traced back to metastases, originated from cancer cells. The presence of metastatic disease, the spread of cancer cells, is the most important prognostic and survival factor in patients with cancer. Although treatment of the primary tumor is well established and usually results in local control, treating metastatic disease is a much more daunting task. At diagnosis, few patients present with clinically detectable metastatic lesions regardless of the clinical prognostic factor. Clinical trials assessing potential therapeutic agents are important in order to define the best specific treatment for a particular patient, which are the basis for patient-oriented research that eventually lead to personalized medicine. This volume aims to comprehensively present the latest research and information about metastasis. Understanding the mechanisms underlying the metastatic phenomenon could have vast implications for the large number of patients who are at a high risk for the development of metastasis.
Bone metastasis. --- Cancer. --- Neoplasms. --- Metastasis --- Genes, Neoplasm --- Neoplastic Processes --- Neoplasms --- Genes --- Genome Components --- Diseases --- Genome --- Genetic Structures --- Genetic Phenomena --- Phenomena and Processes --- Neoplasm Metastasis --- Genes, Tumor Suppressor --- Medicine --- Health & Biological Sciences --- Oncology --- Metastasis. --- Research. --- Cancer --- Cancer metastasis --- Dissemination of cancer --- Metastases --- Metastatic cancer --- Neoplasm metastasis --- Spread of cancer --- Tumor dissemination --- Tumor metastasis --- Tumor spread --- Dissemination --- Medicine. --- Cancer research. --- Pharmacology. --- Biomedicine. --- Cancer Research. --- Pharmacology/Toxicology. --- Pathology --- Cancer invasiveness --- Cancer of unknown primary origin --- Oncology. --- Toxicology. --- Chemicals --- Pharmacology --- Poisoning --- Poisons --- Tumors --- Toxicology --- Drug effects --- Medical pharmacology --- Medical sciences --- Chemotherapy --- Drugs --- Pharmacy --- Cancer research --- Physiological effect
Choose an application
Cancer cells --- Growth. --- Cells --- Pathology, Cellular --- Cancer cell growth --- Tumor Suppressor Proteins. --- Apoptosis. --- Apoptosis, Extrinsic Pathway --- Apoptosis, Intrinsic Pathway --- Caspase-Dependent Apoptosis --- Classic Apoptosis --- Classical Apoptosis --- Programmed Cell Death --- Programmed Cell Death, Type I --- Apoptoses, Extrinsic Pathway --- Apoptoses, Intrinsic Pathway --- Apoptosis, Caspase-Dependent --- Apoptosis, Classic --- Apoptosis, Classical --- Caspase Dependent Apoptosis --- Cell Death, Programmed --- Classic Apoptoses --- Extrinsic Pathway Apoptoses --- Extrinsic Pathway Apoptosis --- Intrinsic Pathway Apoptoses --- Intrinsic Pathway Apoptosis --- Necrosis --- Cell Death --- Clonal Deletion --- Superantigens --- Caspases --- Caspase 1 --- In Situ Nick-End Labeling --- Cellular Apoptosis Susceptibility Protein --- Genes, Transgenic, Suicide --- Growth Suppressor Proteins --- Metastasis Suppressor Proteins --- Proteins, Growth Suppressor --- Proteins, Metastasis Suppressor --- Proteins, Tumor Suppressor --- Genes, Tumor Suppressor --- Apoptosi
Choose an application
Since the discovery of p53 as a tumor suppressor, numerous methods have evolved to reveal its unique structural features and biochemical functions. In p53 Protocols, Sumitra and Swati Palit Deb have assembled an indispensable collection of novel techniques that have proven most useful for studying the physiological properties of p53 both in vitro and in vivo. Described by leading basic and clinical researchers who have successfully used the methods, the techniques provide proven solutions to problems in studying the purification, target identification, gene expression, quantitation, interaction, signaling, transactivation, and transrepression of p53. The methods are also useful for delineating the functions of other proteins that may act as tumor or growth suppressors. Each technique includes step-by-step instructions, troubleshooting notes, a theoretical review, and discussion of associated problems that might arise during the course of investigation. Special effort has been made to discuss problems and their solutions to help ease the learning curve when standardizing a new method. Diverse and highly practical, p53 Protocols offers both beginning and experienced researchers in cancer biology a gold-standard compendium of readily reproducible techniques for studying p53 and related proteins.
Protein p53 --- Tumor Suppressor Proteins --- Genes, p53 --- Neoplasms --- p53 protein --- p53 antioncogene --- Protéine p53 --- Gène p53 --- analysis --- therapeutic use --- physiology --- genetics --- Laboratory manuals --- Manuels de laboratoire --- Electronic books. -- local. --- p53 antioncogene -- Laboratory manuals. --- p53 protein -- Laboratory manuals. --- Tumor Suppressor Protein p53 --- Genetics --- Physiology --- Biological Science Disciplines --- Phosphoproteins --- DNA-Binding Proteins --- Biology --- Genes, Tumor Suppressor --- Nuclear Proteins --- Neoplasm Proteins --- Diseases --- Proteins --- Genes, Recessive --- Natural Science Disciplines --- Genes, Neoplasm --- Disciplines and Occupations --- Amino Acids, Peptides, and Proteins --- Genes --- Chemicals and Drugs --- Genome Components --- Genome --- Genetic Structures --- Genetic Phenomena --- Phenomena and Processes --- Animal Biochemistry --- Cytology --- Human Anatomy & Physiology --- Health & Biological Sciences --- Protéine p53 --- Gène p53 --- p53 gene --- p53 suppressor gene --- Antioncogenes --- Protein TP53 --- TP53 protein --- DNA-binding proteins --- Tumor suppressor proteins --- analysis. --- physiology. --- genetics. --- Cytology. --- Cell Biology. --- Cell biology --- Cellular biology --- Cells --- Cytologists
Choose an application
The initial identification of the Adenomatous polyposis coli (Apc) gene as the site of mutations in familial adenomatous polyposis (FA P) was described in 1992. A causal relationship between Apc mutations and intestinal tract tumours was confirmed three years later with the establishment of the Min mouse model. These mice are heterozygous for Apc and develop numerous intestinal tumours that mimic FA P. Subsequently, Apc has emerged as the most commonly mutated gene in colorectal cancer with reports varying between 50-80 per cent of sporadic tumours carrying such mutations. The search for how m
Adenomatous Polyposis Coli Protein. --- Adenomatous Polyposis Coli. --- Colon (Anatomy) -- Cancer. --- Colorectal Neoplasms -- Metabolism. --- Genes, APC. --- Tumor suppressor proteins. --- Colon (Anatomy) --- Tumor suppressor proteins --- Adenomatous Polyposis Coli --- Colorectal Neoplasms --- Genes, APC --- Metabolism --- Adenomatous Polyposis Coli Protein --- Intestinal Polyposis --- Intestinal Neoplasms --- Colonic Neoplasms --- Neoplastic Syndromes, Hereditary --- Colonic Diseases --- Metabolic Phenomena --- Cytoskeletal Proteins --- Genes, Tumor Suppressor --- Tumor Suppressor Proteins --- Rectal Diseases --- Adenomatous Polyps --- Proteins --- Neoplasm Proteins --- Intestinal Diseases --- Neoplasms --- Genes, Neoplasm --- Phenomena and Processes --- Gastrointestinal Neoplasms --- Genes, Recessive --- Adenoma --- Genetic Diseases, Inborn --- Gastrointestinal Diseases --- Digestive System Neoplasms --- Genes --- Diseases --- Neoplasms, Glandular and Epithelial --- Congenital, Hereditary, and Neonatal Diseases and Abnormalities --- Amino Acids, Peptides, and Proteins --- Chemicals and Drugs --- Digestive System Diseases --- Genome Components --- Neoplasms by Site --- Neoplasms by Histologic Type --- Genome --- Genetic Structures --- Genetic Phenomena --- Oncology --- Medicine --- Health & Biological Sciences --- Cancer --- Cancer. --- Antioncoproteins --- Growth suppressor proteins --- Metastasis suppressor proteins --- Colon cancer --- Colorectal cancer --- Medicine. --- Biomedicine. --- Biomedicine general. --- Clinical sciences --- Medical profession --- Human biology --- Life sciences --- Medical sciences --- Pathology --- Physicians --- Antioncogenes --- Health Workforce --- Biomedicine, general.
Listing 1 - 9 of 9 |
Sort by
|